| GTO ID | GTC2920 |
| Trial ID | NCT05225363 |
| Disease | Ovarian Carcinoma |
| Altered gene | TAG72 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | TAG72 CAR-T cells |
| Phase | Phase1 |
| Recruitment status | Recruiting |
| Title | Modified Immune Cells (TAG72-CAR T Cells) for the Treatment of Patients With Platinum Resistant Epithelial Ovarian Cancer |
| Year | 2022 |
| Country | United States |
| Company sponsor | City of Hope Medical Center |
| Other ID(s) | 20034|NCI-2021-10838|20034|P30CA033572|R01CA266874 |
| Cohort 1 | |||||||||
|
|||||||||